home / stock / pirs / pirs news

PIRS News and Press, Pieris Pharmaceuticals Inc. From 01/31/19

Stock Information
Company Name: Pieris Pharmaceuticals Inc.
Stock Symbol: PIRS
Market: NASDAQ
Website: pieris.com
Menu
PIRS PIRS Quote PIRS Short PIRS News PIRS Articles PIRS Message Board
Get PIRS Alerts

News, Short Squeeze, Breakout and More Instantly...
PIRS - January Barometer Shows Momentum And Forensic Negative Portfolios Are The Hottest

The Portfolio Barometer Using an inductive portfolio model approach that goes where the types of returns in the market are strongest, I monitor different fundamental, value, momentum, forensic, and anomaly portfolios from financial research to create a portfolio barometer. This article conti...
PIRS - Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors

BOSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, respiratory and other diseases, announced today that Pet...

PIRS - Dosing underway in Pieris Pharma's early-stage study of cancer candidate PRS-343; shares up 3%

The first patient has been dosed in a Phase 1 dose-escalation study evaluating Pieris Pharmaceuticals' ( PIRS +2.9% ) PRS-343, combined with Roche's Tecentriq (atezolizumab), in patients with advanced/metastatic HER2-positive solid tumors. More news on: Pieris Pharmaceuticals, Inc., ...

PIRS - Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy

BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc.  (NASDAQ: PIRS) ,   a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, respiratory and other diseases, announced today that...
Previous 10 Next 10